BRAND_ANALYSIS#ASTRAZENECAHEALTH & PHARMA#6 OF 26 IN HEALTH & PHARMAINTERESTING
AstraZeneca
· Public · Updated 22 Nov 2026 07:19 UTC
#115 of 1208 overall by tension · #6 of 26 in Health & Pharma
19Interesting
The Silent Giant
Analysis
AstraZeneca is up 1.03% with a wiki_ratio of 0.958 and a C-score of 58 — one of the more culturally legible pharma brands in the world after COVID vaccine deployment made it a household name in dozens of countries. The near-parity wiki_ratio suggests its public profile matches its business weight almost exactly. The post-pandemic normalization means the brand is no longer crisis-visible, which is probably where it wants to be.
IN THE NEWS (100 articles this week)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly - Reuters
Klygefa (gefurulimab) approved in the US for the treatment of generalised myasthenia gravis (gMG) in adult patients - AstraZeneca
AstraZeneca PLC (AZN) stock price, news, quote and history - Yahoo Finance Singapore